According to Latest Study, the global market for Immune Drugs should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Immune Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Immune Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.

This report studies and analyses global Immune Drugs status and future trends, helps the client to determine the Immune Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Immune Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Immune Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

(2) Global Immune Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(3) China Immune Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(4) Global Immune Drugs key consuming regions, consumption quantity, consumption value and demand structure

(5) Global Immune Drugs key producing regions, capacity, production, and year over year growth

(6) Immune Drugs industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Antares Pharma, Inc.

UCB

Incyte

GSK

Takeda

3S Bio

Horizo​​n Therapeutics

Bristol-Myers Squibb (BMS

Astellas

Eli Lilly

Mitsubishi Tanabe Pharma

Biogen

Pfizer

Sanofi

Roche

Novartis

Johnson & Johnson (J&J)

Amgen

Abbvi

Market segment by Type, covers

Immune Boosting Drugs

Immunosuppressant Drugs

Market segment by Application, can be divided into

Hospital

Clinic

Surgery Center

Others

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Immune Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Immune Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China Immune Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of Immune Drugs, percent & CAGR, 2018-2029

Chapter 5: Immune Drugs industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Immune Drugs Definition

1.2 Global Immune Drugs Market Size and Forecast

1.2.1 By Consumption Value, Global Immune Drugs Market Size，2019-2030

1.2.2 By Sales Quantity, Global Immune Drugs Market Size，2019-2030

1.2.3 Global Immune Drugs Average Selling Price (ASP)，2019-2030

1.3 China Immune Drugs Market Size and Forecast

1.3.1 By Consumption Value, China Immune Drugs Market Size，2019-2030

1.3.2 By Sales Quantity, China Immune Drugs Market Size，2019-2030

1.3.3 China Immune Drugs Average Selling Price (ASP)， 2019-2030

1.4 Share of China Immune Drugs Market with Respect to the Global Market

1.4.1 By Consumption Value, China Immune Drugs Market Share in Global, 2019-2030

1.4.2 By Sales Quantity, China Immune Drugs Market Share in Global, 2019-2030

1.4.3 Immune Drugs Market Size: China VS Global, 2019-2030

1.5 Immune Drugs Market Dynamics

1.5.1 Immune Drugs Market Drivers

1.5.2 Immune Drugs Market Restraints

1.5.3 Immune Drugs Industry Trends

1.5.4 Immune Drugs Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Immune Drugs, Global Market Share by Company, 2019-2024

2.2 By Sales Quantity of Immune Drugs, Global Market Share by Company, 2019-2024

2.3 Immune Drugs Average Selling Price (ASP) by Company, 2019-2024

2.4 Global Immune Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Immune Drugs Concentration Ratio

2.6 Global Immune Drugs Mergers & Acquisitions, Expansion Plans

2.7 Global Immune Drugs Manufacturers Product Type

2.8 Head Office and Immune Drugs Production Site of Key Manufacturer

2.9 Immune Drugs Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Immune Drugs, China Market Share by Company, 2019-2024

3.2 By Sales Quantity of Immune Drugs, China Market Share by Company, 2019-2024

3.3 China Immune Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Immune Drugs Capacity, Output and Capacity Utilization, 2019-2030

4.2 Global Immune Drugs Capacity by Region

4.3 Global Immune Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030

4.4 Global Immune Drugs Production by Region, 2019-2030

4.5 Global Immune Drugs Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Immune Drugs Industry Chain

5.2 Immune Drugs Upstream Analysis

5.2.1 Immune Drugs Core Raw Materials

5.2.2 Main Manufacturers of Immune Drugs Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Immune Drugs Production Mode

5.6 Immune Drugs Procurement Model

5.7 Immune Drugs Industry Sales Model and Sales Channels

5.7.1 Immune Drugs Sales Model

5.7.2 Immune Drugs Typical Distributors

6 Sights by Type

6.1 Immune Drugs Classification

6.1.1 Immune Boosting Drugs

6.1.2 Immunosuppressant Drugs

6.2 By Type, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global Immune Drugs Consumption Value, 2019-2030

6.4 By Type, Global Immune Drugs Sales Quantity, 2019-2030

6.5 By Type, Global Immune Drugs Average Selling Price (ASP), 2019-2030

7 Sights by Application

7.1 Immune Drugs Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.1.3 Surgery Center

7.1.4 Others

7.2 By Application, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global Immune Drugs Consumption Value, 2019-2030

7.4 By Application, Global Immune Drugs Sales Quantity, 2019-2030

7.5 By Application, Global Immune Drugs Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Immune Drugs Consumption Value, 2019 VS 2024 VS 2030

8.2 By Region, Global Immune Drugs Consumption Value, 2019-2030

8.3 By Region, Global Immune Drugs Sales Quantity, 2019-2030

8.4 North America

8.4.1 North America Immune Drugs & Forecasts, 2019-2030

8.4.2 By Country, North America Immune Drugs Market Size Market Share

8.5 Europe

8.5.1 Europe Immune Drugs Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Immune Drugs Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Immune Drugs Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Immune Drugs Market Size Market Share

8.7 South America

8.7.1 South America Immune Drugs Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Immune Drugs Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Immune Drugs Market Size & CAGR, 2019 VS 2024 VS 2030

9.2 By Country, Global Immune Drugs Consumption Value, 2019-2030

9.3 By Country, Global Immune Drugs Sales Quantity, 2019-2030

9.4 U.S.

9.4.1 U.S. Immune Drugs Market Size, 2019-2030

9.4.2 By Type, U.S. Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Immune Drugs Market Size, 2019-2030

9.5.2 By Type, Europe Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China Immune Drugs Market Size, 2019-2030

9.6.2 By Type, China Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Immune Drugs Market Size, 2019-2030

9.7.2 By Type, Japan Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Immune Drugs Market Size, 2019-2030

9.8.2 By Type, South Korea Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Immune Drugs Market Size, 2019-2030

9.9.2 By Type, Southeast Asia Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India Immune Drugs Market Size, 2019-2030

9.10.2 By Type, India Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa Immune Drugs Market Size, 2019-2030

9.11.2 By Type, Middle East & Africa Immune Drugs Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa Immune Drugs Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Antares Pharma, Inc.

10.1.1 Antares Pharma, Inc. Company Information, Head Office, Market Area, and Industry Position

10.1.2 Antares Pharma, Inc. Immune Drugs Models, Specifications, and Application

10.1.3 Antares Pharma, Inc. Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Antares Pharma, Inc. Company Profile and Main Business

10.1.5 Antares Pharma, Inc. Recent Developments

10.2 UCB

10.2.1 UCB Company Information, Head Office, Market Area, and Industry Position

10.2.2 UCB Immune Drugs Models, Specifications, and Application

10.2.3 UCB Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.2.4 UCB Company Profile and Main Business

10.2.5 UCB Recent Developments

10.3 Incyte

10.3.1 Incyte Company Information, Head Office, Market Area, and Industry Position

10.3.2 Incyte Immune Drugs Models, Specifications, and Application

10.3.3 Incyte Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Incyte Company Profile and Main Business

10.3.5 Incyte Recent Developments

10.4 GSK

10.4.1 GSK Company Information, Head Office, Market Area, and Industry Position

10.4.2 GSK Immune Drugs Models, Specifications, and Application

10.4.3 GSK Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.4.4 GSK Company Profile and Main Business

10.4.5 GSK Recent Developments

10.5 Takeda

10.5.1 Takeda Company Information, Head Office, Market Area, and Industry Position

10.5.2 Takeda Immune Drugs Models, Specifications, and Application

10.5.3 Takeda Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Takeda Company Profile and Main Business

10.5.5 Takeda Recent Developments

10.6 3S Bio

10.6.1 3S Bio Company Information, Head Office, Market Area, and Industry Position

10.6.2 3S Bio Immune Drugs Models, Specifications, and Application

10.6.3 3S Bio Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.6.4 3S Bio Company Profile and Main Business

10.6.5 3S Bio Recent Developments

10.7 Horizo​​n Therapeutics

10.7.1 Horizo​​n Therapeutics Company Information, Head Office, Market Area, and Industry Position

10.7.2 Horizo​​n Therapeutics Immune Drugs Models, Specifications, and Application

10.7.3 Horizo​​n Therapeutics Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Horizo​​n Therapeutics Company Profile and Main Business

10.7.5 Horizo​​n Therapeutics Recent Developments

10.8 Bristol-Myers Squibb (BMS

10.8.1 Bristol-Myers Squibb (BMS Company Information, Head Office, Market Area, and Industry Position

10.8.2 Bristol-Myers Squibb (BMS Immune Drugs Models, Specifications, and Application

10.8.3 Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.8.4 Bristol-Myers Squibb (BMS Company Profile and Main Business

10.8.5 Bristol-Myers Squibb (BMS Recent Developments

10.9 Astellas

10.9.1 Astellas Company Information, Head Office, Market Area, and Industry Position

10.9.2 Astellas Immune Drugs Models, Specifications, and Application

10.9.3 Astellas Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Astellas Company Profile and Main Business

10.9.5 Astellas Recent Developments

10.10 Eli Lilly

10.10.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position

10.10.2 Eli Lilly Immune Drugs Models, Specifications, and Application

10.10.3 Eli Lilly Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.10.4 Eli Lilly Company Profile and Main Business

10.10.5 Eli Lilly Recent Developments

10.11 Mitsubishi Tanabe Pharma

10.11.1 Mitsubishi Tanabe Pharma Company Information, Head Office, Market Area, and Industry Position

10.11.2 Mitsubishi Tanabe Pharma Immune Drugs Models, Specifications, and Application

10.11.3 Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.11.4 Mitsubishi Tanabe Pharma Company Profile and Main Business

10.11.5 Mitsubishi Tanabe Pharma Recent Developments

10.12 Biogen

10.12.1 Biogen Company Information, Head Office, Market Area, and Industry Position

10.12.2 Biogen Immune Drugs Models, Specifications, and Application

10.12.3 Biogen Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.12.4 Biogen Company Profile and Main Business

10.12.5 Biogen Recent Developments

10.13 Pfizer

10.13.1 Pfizer Company Information, Head Office, Market Area, and Industry Position

10.13.2 Pfizer Immune Drugs Models, Specifications, and Application

10.13.3 Pfizer Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.13.4 Pfizer Company Profile and Main Business

10.13.5 Pfizer Recent Developments

10.14 Sanofi

10.14.1 Sanofi Company Information, Head Office, Market Area, and Industry Position

10.14.2 Sanofi Immune Drugs Models, Specifications, and Application

10.14.3 Sanofi Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.14.4 Sanofi Company Profile and Main Business

10.14.5 Sanofi Recent Developments

10.15 Roche

10.15.1 Roche Company Information, Head Office, Market Area, and Industry Position

10.15.2 Roche Immune Drugs Models, Specifications, and Application

10.15.3 Roche Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.15.4 Roche Company Profile and Main Business

10.15.5 Roche Recent Developments

10.16 Novartis

10.16.1 Novartis Company Information, Head Office, Market Area, and Industry Position

10.16.2 Novartis Immune Drugs Models, Specifications, and Application

10.16.3 Novartis Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.16.4 Novartis Company Profile and Main Business

10.16.5 Novartis Recent Developments

10.17 Johnson & Johnson (J&J)

10.17.1 Johnson & Johnson (J&J) Company Information, Head Office, Market Area, and Industry Position

10.17.2 Johnson & Johnson (J&J) Immune Drugs Models, Specifications, and Application

10.17.3 Johnson & Johnson (J&J) Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.17.4 Johnson & Johnson (J&J) Company Profile and Main Business

10.17.5 Johnson & Johnson (J&J) Recent Developments

10.18 Amgen

10.18.1 Amgen Company Information, Head Office, Market Area, and Industry Position

10.18.2 Amgen Immune Drugs Models, Specifications, and Application

10.18.3 Amgen Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.18.4 Amgen Company Profile and Main Business

10.18.5 Amgen Recent Developments

10.19 Abbvi

10.19.1 Abbvi Company Information, Head Office, Market Area, and Industry Position

10.19.2 Abbvi Immune Drugs Models, Specifications, and Application

10.19.3 Abbvi Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.19.4 Abbvi Company Profile and Main Business

10.19.5 Abbvi Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Immune Drugs Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Immune Drugs Market Restraints

Table 3. Immune Drugs Market Trends

Table 4. Immune Drugs Industry Policy

Table 5. Global Immune Drugs Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Immune Drugs Revenue Share by Company, 2019-2024, Ranked by Data of 2022

Table 7. Global Immune Drugs Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Immune Drugs Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 9. Global Immune Drugs Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Immune Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Immune Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Immune Drugs Manufacturers Product Type

Table 13. Head Office and Immune Drugs Production Site of Key Manufacturer

Table 14. Immune Drugs Capacity of Major Manufacturers and Future Plan

Table 15. China Immune Drugs Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 16. China Immune Drugs Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 17. China Immune Drugs Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 18. Global Immune Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Immune Drugs Production by Region, 2019-2024, (K Units)

Table 20. Global Immune Drugs Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Immune Drugs Upstream (Raw Materials)

Table 22. Global Immune Drugs Typical Customers

Table 23. Immune Drugs Typical Distributors

Table 24. By Type, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Immune Drugs Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Immune Drugs Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Immune Drugs Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Immune Drugs Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Immune Drugs Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Immune Drugs Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Immune Drugs Sales Quantity Market Share, 2019-2030

Table 34. Antares Pharma, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 35. Antares Pharma, Inc. Immune Drugs Models, Specifications, and Application

Table 36. Antares Pharma, Inc. Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. Antares Pharma, Inc. Company Profile and Main Business

Table 38. Antares Pharma, Inc. Recent Developments

Table 39. UCB Company Information, Head Office, Market Area, and Industry Position

Table 40. UCB Immune Drugs Models, Specifications, and Application

Table 41. UCB Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. UCB Company Profile and Main Business

Table 43. UCB Recent Developments

Table 44. Incyte Company Information, Head Office, Market Area, and Industry Position

Table 45. Incyte Immune Drugs Models, Specifications, and Application

Table 46. Incyte Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Incyte Company Profile and Main Business

Table 48. Incyte Recent Developments

Table 49. GSK Company Information, Head Office, Market Area, and Industry Position

Table 50. GSK Immune Drugs Models, Specifications, and Application

Table 51. GSK Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. GSK Company Profile and Main Business

Table 53. GSK Recent Developments

Table 54. Takeda Company Information, Head Office, Market Area, and Industry Position

Table 55. Takeda Immune Drugs Models, Specifications, and Application

Table 56. Takeda Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Takeda Company Profile and Main Business

Table 58. Takeda Recent Developments

Table 59. 3S Bio Company Information, Head Office, Market Area, and Industry Position

Table 60. 3S Bio Immune Drugs Models, Specifications, and Application

Table 61. 3S Bio Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. 3S Bio Company Profile and Main Business

Table 63. 3S Bio Recent Developments

Table 64. Horizo​​n Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 65. Horizo​​n Therapeutics Immune Drugs Models, Specifications, and Application

Table 66. Horizo​​n Therapeutics Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Horizo​​n Therapeutics Company Profile and Main Business

Table 68. Horizo​​n Therapeutics Recent Developments

Table 69. Bristol-Myers Squibb (BMS Company Information, Head Office, Market Area, and Industry Position

Table 70. Bristol-Myers Squibb (BMS Immune Drugs Models, Specifications, and Application

Table 71. Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Bristol-Myers Squibb (BMS Company Profile and Main Business

Table 73. Bristol-Myers Squibb (BMS Recent Developments

Table 74. Astellas Company Information, Head Office, Market Area, and Industry Position

Table 75. Astellas Immune Drugs Models, Specifications, and Application

Table 76. Astellas Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Astellas Company Profile and Main Business

Table 78. Astellas Recent Developments

Table 79. Eli Lilly Company Information, Head Office, Market Area, and Industry Position

Table 80. Eli Lilly Immune Drugs Models, Specifications, and Application

Table 81. Eli Lilly Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Eli Lilly Company Profile and Main Business

Table 83. Eli Lilly Recent Developments

Table 84. Mitsubishi Tanabe Pharma Company Information, Head Office, Market Area, and Industry Position

Table 85. Mitsubishi Tanabe Pharma Immune Drugs Models, Specifications, and Application

Table 86. Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Mitsubishi Tanabe Pharma Company Profile and Main Business

Table 88. Mitsubishi Tanabe Pharma Recent Developments

Table 89. Biogen Company Information, Head Office, Market Area, and Industry Position

Table 90. Biogen Immune Drugs Models, Specifications, and Application

Table 91. Biogen Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Biogen Company Profile and Main Business

Table 93. Biogen Recent Developments

Table 94. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 95. Pfizer Immune Drugs Models, Specifications, and Application

Table 96. Pfizer Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Pfizer Company Profile and Main Business

Table 98. Pfizer Recent Developments

Table 99. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 100. Sanofi Immune Drugs Models, Specifications, and Application

Table 101. Sanofi Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Sanofi Company Profile and Main Business

Table 103. Sanofi Recent Developments

Table 104. Roche Company Information, Head Office, Market Area, and Industry Position

Table 105. Roche Immune Drugs Models, Specifications, and Application

Table 106. Roche Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Roche Company Profile and Main Business

Table 108. Roche Recent Developments

Table 109. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 110. Novartis Immune Drugs Models, Specifications, and Application

Table 111. Novartis Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. Novartis Company Profile and Main Business

Table 113. Novartis Recent Developments

Table 114. Johnson & Johnson (J&J) Company Information, Head Office, Market Area, and Industry Position

Table 115. Johnson & Johnson (J&J) Immune Drugs Models, Specifications, and Application

Table 116. Johnson & Johnson (J&J) Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 117. Johnson & Johnson (J&J) Company Profile and Main Business

Table 118. Johnson & Johnson (J&J) Recent Developments

Table 119. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 120. Amgen Immune Drugs Models, Specifications, and Application

Table 121. Amgen Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 122. Amgen Company Profile and Main Business

Table 123. Amgen Recent Developments

Table 124. Abbvi Company Information, Head Office, Market Area, and Industry Position

Table 125. Abbvi Immune Drugs Models, Specifications, and Application

Table 126. Abbvi Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 127. Abbvi Company Profile and Main Business

Table 128. Abbvi Recent Developments

List of Figures

Figure 1. Immune Drugs Picture

Figure 2. Global Immune Drugs Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Immune Drugs Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Immune Drugs Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Immune Drugs Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Immune Drugs Sales Quantity (K Units) & (2019-2030)

Figure 7. China Immune Drugs Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Immune Drugs Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Immune Drugs Market Share of Global, 2019-2030

Figure 10. Global Immune Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Immune Drugs Key Participants, Market Share, 2022

Figure 12. Global Immune Drugs Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Immune Drugs Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Immune Drugs Production Market Share & Forecast by Region, 2019-2030

Figure 15. Immune Drugs Industry Chain

Figure 16. Immune Drugs Procurement Model

Figure 17. Immune Drugs Sales Model

Figure 18. Immune Drugs Sales Channels, Direct Sales, and Distribution

Figure 19. Immune Boosting Drugs

Figure 20. Immunosuppressant Drugs

Figure 21. By Type, Global Immune Drugs Consumption Value, 2019-2030, US$ Million

Figure 22. By Type, Global Immune Drugs Consumption Value Market Share, 2019-2030

Figure 23. By Type, Global Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 24. By Type, Global Immune Drugs Sales Quantity Market Share, 2019-2030

Figure 25. By Type, Global Immune Drugs Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 26. Hospital

Figure 27. Clinic

Figure 28. Surgery Center

Figure 29. Others

Figure 30. By Application, Global Immune Drugs Consumption Value, 2019-2030, US$ Million

Figure 31. By Application, Global Immune Drugs Consumption Value Market Share, 2019-2030

Figure 32. By Application, Global Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 33. By Application, Global Immune Drugs Sales Quantity Market Share, 2019-2030

Figure 34. By Application, Global Immune Drugs Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 35. By Region, Global Immune Drugs Consumption Value Market Share, 2019-2030

Figure 36. By Region, Global Immune Drugs Sales Quantity Market Share, 2019-2030

Figure 37. North America Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 38. By Country, North America Immune Drugs Consumption Value Market Share, 2022

Figure 39. Europe Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 40. By Country, Europe Immune Drugs Consumption Value Market Share, 2022

Figure 41. Asia Pacific Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 42. By Country/Region, Asia Pacific Immune Drugs Consumption Value Market Share, 2022

Figure 43. South America Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, South America Immune Drugs Consumption Value Market Share, 2022

Figure 45. Middle East & Africa Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 46. U.S. Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 47. By Type, U.S. Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 48. By Application, U.S. Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 49. Europe Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 50. By Type, Europe Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 51. By Application, Europe Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 52. China Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 53. By Type, China Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 54. By Application, China Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 55. Japan Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 56. By Type, Japan Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 57. By Application, Japan Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 58. South Korea Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 59. By Type, South Korea Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 60. By Application, South Korea Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 61. Southeast Asia Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 62. By Type, Southeast Asia Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 63. By Application, Southeast Asia Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 64. India Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 65. By Type, India Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 66. By Application, India Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 67. Middle East & Africa Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 68. By Type, Middle East & Africa Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 69. By Application, Middle East & Africa Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up and Top-down Approaches

Figure 73. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)